AB-FUBINACA has been discovered only in recent times and it is one chemical compound which can definitely serve as a normal replacement for the various natural cannabis. However, that being said, normal cannabis are generally illegal in plenty countries all over the world.
This product belongs to the cannabinoid family when it comes to the chemical compounds. The effects of this medicine are same as of cannabis. However, IT works really well because of the high level of purity of this compound and therefore the effects are greatly compounded too. Because of the high purity of AB-FUBINACA, it is advised that users take this only in very small dosages.
5F-ADB is a chemical research compound that is closely related to AB-CHMINACA. The IUPAC name for 5F-ADB is: methyl (R)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate.
Since 5F-ADB is a new compound research on the compound has not been published. However, since it is similar to AB-CHMINACA we can use research data conducted on this chemical to learn more about 5F-ADB.
Properties that were predicted by ChemAxon included a topology analysis, which showed an atom count of 28, bond count of 28, cyclomatic number of 1, chain atom count of 5, chain bond count of 4, asymmetric atom count of 1, and rotatable bond count of 2.
5F-ADB (also known as 5F-MDMB-PINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family, which has been used as an active ingredient in synthetic cannabis products.
5F-ADB is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target. 5F-ADB was first identified in November 2014 from post-mortem samples taken from an individual who had died after using a product containing this substance.
Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014, and it was added to the Japanese banned drug list in December 2014.
5F-ADB is believed to be extremely potent based on the very low levels detected in tissue samples, and appears to be significantly more toxic than earlier synthetic cannabinoid drugs that had previously been sold.